Skip to main content
Livermore
Livermore
ZHEN

Barclays PLC

SEC CIK
0000312069
Latest filing
Aug 14, 2026

KNSA holding history

Kiniksa Pharmaceuticals International, plc in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KNSA overviewAll 13F holders of KNSAFull Q2 2026 holdings

Shares (Q2 2026)
13,162
Value
$841.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of KNSA by Barclays PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,162$841.7K<0.1%−20,990−61.5%ReducedHolders
Q1 202634,152$1.64M<0.1%+29,575+646.2%AddedHolders
Q4 20254,577$188.8K<0.1%−2,776−37.8%ReducedHolders
Q3 20257,353$285.5K<0.1%−4,699−39.0%ReducedHolders
Q2 202512,052$333.5K<0.1%−43,291−78.2%ReducedHolders
Q1 202555,343$1.23M<0.1%−16,553−23.0%ReducedHolders
Q4 202471,896$1.42M<0.1%+7,267+11.2%AddedHolders
Q3 202464,629$1.62M<0.1%+29,790+85.5%AddedHolders
Q2 202434,839$650.4K<0.1%−7,308−17.3%ReducedHolders
Q1 202442,147$831.6K<0.1%−143,609−77.3%ReducedHolders
Q4 2023185,756$3.26M<0.1%+10,231+5.8%AddedHolders
Q3 2023175,525$3.05M<0.1%+12,867+7.9%AddedHolders
Q2 2023162,658$2.29M<0.1%+479+0.3%AddedHolders
Q1 2023162,179$1.75M<0.1%+102,172+170.3%AddedHolders
Q4 202260,007$898.9K<0.1%+37,666+168.6%AddedHolders
Q3 202222,341$287.0K<0.1%+5,969+36.5%AddedHolders
Q2 202216,372$158.0K<0.1%−3,289−16.7%ReducedHolders
Q1 202219,661$195.0K<0.1%−35,873−64.6%ReducedHolders
Q4 202155,534$653.0K<0.1%−21,026−27.5%ReducedHolders
Q3 202176,560$872.0K<0.1%+56,731+286.1%AddedHolders
Q2 202119,829$275.0K<0.1%−235,707−92.2%ReducedHolders
Q1 2021255,536$4.73M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.